January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting

FDA Expert Panel on Testosterone Replacement Therapy for Men

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Medical Device Quality Management System Regulation Risk Management

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Medical Device Quality Management System Regulation Design and Development

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

FDA Direct: FDA Awards Six National Priority Vouchers

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S08 – Symposium Wrap-up and...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

2025 FDA Achievements